PET/CT显像在卵巢癌患者术后复发与转移中的应用效果

摘要
图/表
参考文献(15)
相关文章 (15)

全文: PDF (0 KB) HTML (31 KB)
输出: BibTeX | EndNote (RIS)

摘要目的为了提高临床对卵巢癌术后复发与转移的检出率，分析PET/CT 显像在卵巢癌患者术后复发与转移中的应用效果。方法选取2016年7月～2017年7月在本院手术治疗且术后病理诊断为卵巢癌的47 例患者作为研究对象，所有患者均在术后随访过程中行PET/CT 检查和常规影像学检查（如CT、超声等），并经再次手术后病理学检查、多种影像学检查和临床随访而确诊术后复发或转移，比较PET/CT 检查与常规检查方法的敏感性、特异性、准确性及术后转移或复发患者血清中的CA125 水平检出阳性率。结果 PET/CT 显像对卵巢癌术后复发与转移灶检测的敏感性、特异性、准确性分别为80.13%、79.55%、83.22%，高于常规影像学检查的68.55%、58.65%、63.86%，差异有统计学意义（P＜0.05）；术后转移或复发患者血清中CA125 水平升高者37 例（78.72%），PET/CT 显像阳性率为94.59%（35/37），高于常规影像学检查的78.38%（29/37），差异有统计学意义（P＜0.05）。结论卵巢癌术后考虑复发与转移的患者行PET/CT 显像检测较常规影像学检查方法具有准确性高、敏感性好、特异性强的优点，对于同时伴有血清CA125 升高的患者，应用PET/CT 检测其灵敏度显著高于常规影像学检查方法，值得临床应用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	伍日照
	黄斌豪
	邹伟强
	段晓蓓
	秦贵磷
	周锦俊
	吴月娥

关键词 ： PET/CT 显像, 卵巢癌, 术后复发与转移, 常规影像学检查

Abstract： Objective In order to improve the detection rate of recurrence and metastasis of ovarian cancer after operation, and to analyze the application effect of PET/CT imaging in recurrence and metastasis of ovarian cancer after operation.Methods A total of 47 patients with ovarian cancer who underwent surgery in our hospital from July 2016 to July 2017 were selected as the study subjects.All patients underwent PET/CT examination and routine imaging examination (such as CT, ultrasound, etc.) during the follow-up period, and were confirmed to have recurrence or metastasis after reoperation by pathological examination, multiple imaging examinations and clinical follow-up.Sensitivity, specificity, accuracy, and positive rate of serum CA125 level in patients with metastasis or recurrence after operation were compared by PET/CT and routine methods.Results The sensitivity, specificity and accuracy of PET/CT imaging in detecting recurrence and metastasis of ovarian cancer after operation were 80.13%, 79.55% and 83.22% respectively,which were higher than 68.55%, 58.65% and 63.86% of routine imaging examination (P＜0.05).Serum CA125 level increased in 37 patients with metastasis or recurrence after operation (78.72%), the positive rate of imaging was 94.59%(35/37), which was higher than 78.38% (29/37) of routine imaging examination, and the difference was statistically significant (P＜0.05).Conclusion PET/CT imaging for patients with ovarian cancer considering recurrence and metastasis after operation has the advantages of higher accuracy, better sensitivity and specificity than routine imaging examination.For patients with elevated serum CA125, it should be used.The sensitivity of PET/CT is significantly higher than that of conventional imaging methods, which is worthy of clinical application.

Key words： PET/CT imaging Ovarian cancer Recurrence and metastasis after surgery Routine imaging examination

基金资助:广东省江门市医疗卫生领域科技计划项目（2016 020400350002158—04）

作者简介: 伍日照（1978-），男，广东江门人，副主任医师，研究方向：肿物影像学

引用本文:

伍日照；黄斌豪；邹伟强；段晓蓓；秦贵磷；周锦俊；吴月娥. PET/CT显像在卵巢癌患者术后复发与转移中的应用效果[J]. 中国当代医药, 2019, 26(12): 112-114.
WU Ri-zhao； HUANG Bin-hao ；ZOU Wei-qiang； DUAN Xiao-bei； QIN Gui-lin ；ZHOU Jin-jun ；WU Yue-e. Application of PET/CT imaging in recurrence and metastasis of ovarian cancer after operation. 中国当代医药, 2019, 26(12): 112-114.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2019/V26/I12/112

[1]	Zheng LE，Qu JY，He F.The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer[J].Open Med（Wars），2016，11（1）：125-132.
[2]	Guo N，Peng Z.Does serum CA125 have clinical value for follow-up monitoring of postoperative patients withepithelial ovarian cancer？Results of a 12-year study[J].J Ovarian Res，2017，10（1）：14.
[3]	秦雪，刘鑫丽，王欣彦，等.血清CA125 变化与上皮性卵巢癌预后及复发关系研究[J].中国实用妇科与产科杂志，2016，32（5）：473-476.
[4]	Lee M，Lee H，Cheon G，et al.Prognostic value of preoperative intratumoral FDG uptake heterogeneity in patients with epithelial ovar-ian cancer[J].J Eur Radiol，2017，27（1）：16-23.
[5]	Rusu D，Carlier T，Colombié M，et al.Clinical and survival im-pact of FDG PET in patients with suspicion of recurrent ovarian can-cer：a 6-year follow-up[J].Front Med（Lausanne），2015，2：46-52.
[6]	张海燕，王瑾，刘斌，等.术前血清CA125 水平与上皮性卵巢癌临床病理特征及预后的关系[J].肿瘤学杂志，2013，19（2）：94-98.
[7]	Fularz M，Adamiak P，Czepczyński R，et al.Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA125 serum level[J].Nuklearmedizin，2015，54（4）：158-162.
[8]	吴丽玲.CA125 测定对卵巢癌早期诊断及预后监测的临床意义[J].中外医疗，2015，19（1）：24-25.
[9]	贺贵福，宋炳胜，赵义，等.CEA?CA125 升高水平与PET/CT 显像评估卵巢癌治疗后复发及转移的价值[J].中国老年学杂志，2015，35（6）：1494-1496.
[10]	杜立平，于晶峰，王雪梅，等.血清CA125 检测联合PET/CT 显像对早期卵巢癌诊断的价值研究[J].内蒙古医科大学学报，2014，36（1）：6-10.
[11]	胡莹莹，樊卫.18F-脱氧葡萄糖PET/CT 在上皮性卵巢癌中的应用进展[J].肿瘤影像学，2016，25（1）：6-10.
[12]	刘为英，高沁怡，李亚明，等.18F-FDG PET 诊断卵巢癌转移和复发的价值[J].中国医科大学学报，2013，42（4）：366-368.
[13]	宋玉琴，朱军.PET-CT 在淋巴瘤中的应用价值[J].中华血液学杂志，2014，35（4）：280-281.
[14]	陈忠，施冬辉，蒋小冬，等.PET-CT 对卵巢癌复发及转移的监测价值[J].中国现代医生，2014，52（33）：131-133.
[15]	Yang ZJ，Zhao BB，Li L.The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer[J].J Ovarian Res，2016，9（1）：57.